Drug Shortage Report for PMS-ROSUVASTATIN
Report ID | 48563 |
Drug Identification Number | 02378566 |
Brand name | PMS-ROSUVASTATIN |
Common or Proper name | ROSUVASTATIN |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | ROSUVASTATIN |
Strength(s) | 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-05-07 |
Actual start date | 2018-05-16 |
Estimated end date | 2018-06-19 |
Actual end date | 2018-06-06 |
Shortage status | Resolved |
Updated date | 2018-06-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-06-07 | English | Compare |
v7 | 2018-06-06 | French | Compare |
v6 | 2018-06-06 | English | Compare |
v5 | 2018-05-18 | French | Compare |
v4 | 2018-05-18 | English | Compare |
v3 | 2018-05-08 | English | Compare |
v2 | 2018-05-04 | French | Compare |
v1 | 2018-05-04 | English | Compare |
Showing 1 to 8 of 8